A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1.
10.1097/CM9.0000000000002810
- Author:
Haisheng YU
1
;
Pengle GUO
;
Yingyin YANG
;
Jun DAI
;
Xiaoping TANG
;
Linghua LI
Author Information
1. Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510440, China.
- Publication Type:Journal Article
- MeSH:
Humans;
COVID-19 Vaccines/therapeutic use*;
HIV-1;
Immunity, Humoral;
COVID-19/prevention & control*;
SARS-CoV-2
- From:
Chinese Medical Journal
2023;136(18):2243-2245
- CountryChina
- Language:English
